ArticleBlood cancer journal2022

Body mass index and risk of progression from monoclonal gammopathy of undetermined significance to multiple myeloma: Results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Vicky C Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.